Abstract
Background
Inappropriate antimicrobial therapy of Staphylococcus aureus bacteremia (SAB) is associated with worsened outcomes. The impact of insurance coverage on appropriate selection of antibiotics at discharge is poorly understood.
Methods
We used a retrospective cohort design to evaluate whether patients with SAB at a large academic medical center over 2 years were more likely to receive inappropriate discharge antibiotics, depending on their category of insurance. Insurance was classified as Medicare, Medicaid, commercial and none. Logistic regression was used to determine the odds of being prescribed inappropriate discharge therapy.
Results
A total of 273 SAB met inclusion criteria with 14.3% receiving inappropriate discharge therapy. In the unadjusted model, there was 2-fold increased odds of being prescribed inappropriate therapy for Medicare, Medicaid, and no insurance, compared to commercial insurance, respectively (OR 2.08, 95% CI 1.39-3.13). After controlling for discharge with nursing assistance and ID consult, there was 1.6-fold increased odds (OR 1.57, 95% CI 0.998-2.53, p=0.064) of being prescribed inappropriate therapy for Medicare, Medicaid, and no insurance, compared to commercial insurance, respectively. We found that being discharged home without nursing assistance resulted in 4-fold increased odds of being prescribed inappropriate therapy (OR 4.16, 95% CI 1.77-9.77, p<0.01) and failing to consult an ID team resulted in 59-fold increased odds of being prescribed inappropriate therapy (OR 59.2, 95% CI 11.4-306.9, p<0.001).
Conclusions
We found strong evidence that non-commercial insurance, discharging without nursing assistance, and failure to consult ID are risk factors for being prescribed inappropriate antimicrobial therapy for SAB upon hospital discharge.